Sell a disease to sell a drug
▻http://www.washingtonpost.com/opinions/the-bulked-up-campaign-around-low-testosterone/2015/06/07/a9abda16-0573-11e5-8bda-c7b4e9a8f7ac_story.html
7 ans, des millions de dollars de profits et x victimes plus tard, la #FDA sort de sa torpeur
Seven years, at least 25 million prescriptions and $9.7 billion in sales too late, the Food and Drug Administration is finally pushing back against the over-prescribing of testosterone.
Last month, in response to new FDA rules, testosterone manufacturers released new instructions for doctors making it clear that testosterone is not approved for “low-T” — a marketing term developed by drug companies to describe men with low testosterone levels caused by aging. Companies must now warn doctors about a possible increased risk of heart attack and stroke in men who take these drugs.